TEST DIRECTORY

AND OR

TOP
endocrinology test
thyroid hormones and their binding protein

Laboratory：Hachioji

○thyroid hormones and their binding protein

TEST NAME	SPECIMEN REQUIREMENT （ｍL）	CONTAINER	CAP COLOR	STORE TEMPERATURE (STABILITY)	TURNAROUND TIME (DAY)	METHODOLOGY	REFERENCE RANGE (UNIT)
Thyroxine binding globulin (TBG)	serum 0.5	S09 ↓ A00			2ｰ4	CLEIA CLEIA(Chemiluminescent enzyme immunoassay) 化学発光酵素免疫測定法固相化した抗体に対して抗原を反応させた後，酵素標識した抗体を抗原に2次反応させ，化学発光基質を加えて発光強度を測定する方法。	14-31(μg/mL)
Free thyroxine (Free T₄)（Suspended beyond orders placed 09-30-2021）	serum 0.3	S09 ↓ A00			2-4	ECLIA Electro chemiluminescence immunoassay (ECLIA) Antibody-bound beads are reacted with antigens that are secondarily reacted with antibodies labeled with rutheniumpyridine complexes, which promotes the electrochemical reaction. The emission intensity of ruthenium-pyridine complexes is measured.	0.90-1.70 (ng/dL)
Thyroxine (T₄)（Suspended beyond orders placed 09-30-2021）	serum 0.3	S09 ↓ A00			2-4	ECLIA Electro chemiluminescence immunoassay (ECLIA) Antibody-bound beads are reacted with antigens that are secondarily reacted with antibodies labeled with rutheniumpyridine complexes, which promotes the electrochemical reaction. The emission intensity of ruthenium-pyridine complexes is measured.	6.10-12.4 (μg/dL)
Triiodothyronine (T₃)（Suspended beyond orders placed 09-30-2021）	serum 0.3	S09 ↓ A00			2-4	ECLIA Electro chemiluminescence immunoassay (ECLIA) Antibody-bound beads are reacted with antigens that are secondarily reacted with antibodies labeled with rutheniumpyridine complexes, which promotes the electrochemical reaction. The emission intensity of ruthenium-pyridine complexes is measured.	0.80-1.60 (ng/mL)
Thyroglobulin（Suspended beyond orders placed 09-30-2021）	serum 0.5	S09 ↓ A00			2-4	ECLIA Electro chemiluminescence immunoassay (ECLIA) Antibody-bound beads are reacted with antigens that are secondarily reacted with antibodies labeled with rutheniumpyridine complexes, which promotes the electrochemical reaction. The emission intensity of ruthenium-pyridine complexes is measured.	≦ 33.7 (ng/mL)
Thyroxine binding globulin (TBG), quantitative（Suspended beyond orders placed 05-29-2020）	serum 0.2	S09 ↓ A00			2-6	RIA PEG method Radio immunoassay (RIA) A target antigen is labeled with radioactive isotope (RI) and bound to its specific antibodies which is then competitively reacted with an antigen in a specimen. After the antigen-antibody reaction, the bound labeled antigens (bound) are separated from the unbound ones (free), and the antigen concentration is determined based on the proportion of radioactivity. 　To separate the bound and free antigens (B/F separation), the following methods are used. Solid-phase method:Antibodies are linked to the solid phase. Double antibody method: Antigen-antibody complexes are bound to the second antibody and precipitated. Ammonium sulfate precipitation method: Antigen-antibody complexes are precipitated by ammonium sulfate. PEG method: Antigenantibody complexes are precipitated by a precipitation reagent.	15.9-35.6 (μg/mL)
Free triiodothyronine (Free T₃)（Suspended beyond orders placed 09-30-2021）	serum 0.3	S09 ↓ A00			2-4	ECLIA Electro chemiluminescence immunoassay (ECLIA) Antibody-bound beads are reacted with antigens that are secondarily reacted with antibodies labeled with rutheniumpyridine complexes, which promotes the electrochemical reaction. The emission intensity of ruthenium-pyridine complexes is measured.	2.30-4.30 (pg/mL)